Wybierz swój kraj lub region

Teraz jesteś w Poland (Polski)
Strona główna / O nas / Investors / Newsroom / Arjo announces date of 2019 Q3 report and conference call
The share Arjo B 25 kwi 2024 09:56 4,10 EUR (+0,63%)
❮ Aktualności

Arjo announces date of 2019 Q3 report and conference call

 

Arjo will issue its Q3 report for 2019 on Tuesday October 22 at 13:00 CET, followed by a conference call at 14:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO. The previously communicated date of October 23 has been altered for practical reasons.

We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference. 

Swedish dial-in number: +46 (0)8 5065 3942
UK: +44 (0)330 336 9411
USA: +1 323-794-2597
Participant passcode: 9981140

During the telephone conference, a presentation will be held. To access the presentation, please use this link: https://slideassist.webcasts.com/starthere.jsp?ei=1264236

Alternatively, use the following link to download the presentation: https://www.arjo.com/int/about-us/investors/reports--presentations/2019/

Agenda

13:45              Call in to the conference
14:00              Review of the Q2 report
14.30              Q&A
15.00              End of conference

A recorded version of the conference is accessible for 90 days via the following link: https://slideassist.webcasts.com/starthere.jsp?ei=1264236

For more information, please contact:                                                                                              

Kornelia Rasmussen, EVP Marketing Communications & Public Relations
Tel: +46(0)10 335 4810
E-mail:
kornelia.rasmussen@arjo.com

Saloni Deva, Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4867
Email:
saloni.deva@arjo.com

About Arjo

At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has approximately 6,000 employees worldwide and customers in over 100 countries. In 2018, Arjo sales amounted to SEK 8.2 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com

Arjo announces date of 2019 Q3 report and conference call

Strona zawiera materiały przeznaczone wyłącznie dla profesjonalistów z branży medycznej lub farmaceutycznej (przedstawiciele zawodów medycznych, w tym pracownicy aptek, laboratoriów diagnostycznych, podmiotów leczniczych, itp.).

Jeżeli nie jesteś profesjonalistą z branży medycznej lub farmaceutycznej zaznacz to w odpowiedzi poniżej. W przeciwnym razie uzyskasz dostęp do materiałów niedopuszczalnych dla Ciebie ze względu na obowiązujące przepisy prawa dotyczące reklamy wyrobów medycznych.

Nie jestem profesjonalistą
Kontakt